Skip to main content

Organigram Global Inc(OGI-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low1.4100
Day High1.4800
Open:1.4600
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Organigram Closes Sanity Group Deal, Bolsters European Cannabis Push With New Financing
Organigram Closes Previously Announced Acquisition of Sanity Group, Private Placement Financing with BAT and ATB Senior Secured Credit Facilities
Organigram Wins Shareholder Backing for Sanity Group Deal and Board Slate
Organigram Shareholders Back Sanity Group Deal, Deepening European Cannabis Push
Organigram Announces Shareholder Approval of Acquisition of Sanity Group GmbH and Results of its Annual General and Special Meeting
ISS Backs Organigram’s Premium-Priced Acquisition of Sanity Group
Organigram Announces Independent Proxy Advisory Firm ISS Recommends Organigram Shareholders Vote FOR the Acquisition of Sanity Group GmbH
Organigram Sets March 30 Vote on Sanity Group Acquisition and BAT-Funded Expansion
Organigram Global Sets March 30 Vote on Transformative Acquisition of Germany’s Sanity Group
Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting
Organigram Extends SHRED Brand Into Fast-Acting Shot-Sized Cannabis Beverages
Organigram Global Expands FAST™ Innovation Platform with SHRED Shotz, Leveraging SHRED Brand Equity
Organigram Global Moves to Acquire Germany’s Sanity Group in Financed Deal with BAT Support
Organigram Expands Global Footprint With New Medical Cannabis Products in Australia
Organigram Further Expands Global Portfolio with Launch of Edison and BOXHOT Medical Vapes and Pastilles in Australia
Organigram Global Moves to Acquire Stake in Germany’s Sanity Group, Expanding European Cannabis Reach
Analysts Offer Insights on Healthcare Companies: Organigram Global (OGI) and Spyre Therapeutics (SYRE)
Analysts Offer Insights on Healthcare Companies: OrganiGram Holdings (OGI), Taysha Gene Therapies (TSHA) and BioRestorative Therapies (BRTX)
Organigram Secures C$65.2 Million BAT Investment to Back Sanity Group Deal
Analysts Offer Insights on Healthcare Companies: OrganiGram Holdings (OGI) and Qiagen (QGEN)
Alliance Global Partners Reaffirms Their Buy Rating on OrganiGram Holdings (OGI)
Organigram to Acquire Germany’s Sanity Group in Major European Cannabis Push
Organigram Announces C$65.2 Million BAT Private Placement Investment in Connection with the Acquisition of Sanity Group
Organigram Announces Proposed Acquisition of Sanity Group, a Leading German Cannabis Company
Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY), Quest Diagnostics (DGX) and OrganiGram Holdings (OGI)
Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL) and OrganiGram Holdings (OGI)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Zimmer Biomet Holdings (ZBH) and OrganiGram Holdings (OGI)
Organigram Delivers Strong Q1 2026 Growth and Expands U.S. Reach
Organigram Reports First Quarter Fiscal 2026 Results
Organigram Sets February 10 Date to Release Q1 2026 Results
Organigram to Report First Quarter Fiscal 2026 Results on February 10, 2026
OrganiGram Sets March 30, 2026 Date for Annual and Special Shareholder Meeting

Profile

Organigram Global Inc. is focused on producing cannabis for adult recreational consumers. Organigram Global Inc., formerly known as OrganiGram Holdings Inc, is based in TORONTO.